×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

GE Healthcare Announces Agreement with Research Group at Karolinska Institutet, Sweden to Provide Next Generation Sequencing Services

September 27, 2013

First project to focus on determining root cause of metastatic cancer through gene sequencing

business unit
tags
Press Release

Lengthy Neurological Diagnosis Delay May Impact Patients, Survey Shows

September 19, 2013

Opinion Survey examines delays in diagnosis of Alzheimer's, Parkinson's and Multiple Sclerosis

business unit
tags
Press Release

SCCT Presentations Showcase GE Healthcare's Innovative Technologies Designed for the Toughest Challenges in Cardiac CT Imaging

July 12, 2013

Montreal, Quebec, CANADA -- GE Healthcare's newest CT technologies will be discussed in multiple presentations at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting, which opened today. Satur

business unit
tags
Press Release

Clarient, A GE Healthcare Company, Introduces First Lab Developed Test To Assess Multiple Proteins at Single-Cell Level

July 10, 2013

business unit
tags
Press Release

GE Healthcare Announces Commercial Availability of New Methodology That Provides a Cancer Profile on a Single Slide

May 31, 2013

--Groundbreaking method uses quantitative protein analysis to identify new biosignatures, for personalized treatments--

business unit
tags
Press Release

GE Healthcare Presents Parkinsonian Syndromes and Alzheimer's Disease Research Data and Introduces New Products at Society of Nuclear Medicine and Molecular Imaging Annual Meeting

May 30, 2013

Company Showcases Innovative Hardware, Software and Radiopharmaceutical Solutions

business unit
tags
Press Release

GE Healthcare and Eisai Inc. to Partner on Alzheimer's Disease Research

April 24, 2013

Eisai Initiates Phase I Trial of BACE Inhibitor Utilizing GE's [18F]Flutemetamol

business unit
tags
Press Release

GE Healthcare Presents at 2013 BIO International Convention on Role of Precision Diagnostics and Reimbursement Policy

April 23, 2013

Chief Executive Officer for Medical Diagnostics Pascale Witz Serves on Industry Panel

business unit
tags
Press Release

FDA Approves GE Healthcare's AdreView™ (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients

March 22, 2013

AdreView is the First and Only Imaging Agent Approved for Visualization of Myocardial Sympathetic Innervation in Certain Heart Failure Patients

business unit
tags
Press Release

New [18F]Flutemetamol Data Presented by GE Healthcare at 7th Annual Human Amyloid Imaging Conference

January 18, 2013

Miami, FL -- January 18, 2013-- Study data presented by GE Healthcare at the 7th Annual Human Amyloid Imaging (HAI) meeting in Miami suggest that GE Healthcare's electronic training program (ETP) used to teach interpretation of images taken using the investigational PET imaging agent [18F]flutemetamol was highly effective in training inexperienced readers.

business unit
tags
Subscribe to Medical Diagnostics